Intellia Therapeutics Inc (NTLA) — Capital Reinvestment Ratio
Intellia Therapeutics Inc (NTLA) has a Capital Reinvestment Ratio of 0.02x as of June 2020, meaning it reinvests 0% of its operating cash flow ($57.42 Million) in capital expenditures ($1.04 Million). Check NTLA tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Intellia Therapeutics Inc Capital Reinvestment Ratio (2016–2016)
This chart tracks Intellia Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see NTLA cash generation efficiency.
Annual Capital Reinvestment Ratio for Intellia Therapeutics Inc (2016–2016)
Year-by-year Capital Reinvestment Ratio for Intellia Therapeutics Inc from 2016 to 2016. See Intellia Therapeutics Inc (NTLA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.17x | $36.11 Million | $6.17 Million | — |